Selected article for: "previous study and study infection"

Author: Lin, Tsai-Yu; Chin, Christopher R.; Everitt, Aaron R.; Clare, Simon; Perreira, Jill M.; Savidis, George; Aker, Aaron M.; John, Sinu P.; Sarlah, David; Carreira, Erick M.; Elledge, Stephen J.; Kellam, Paul; Brass, Abraham L.
Title: Amphotericin B Increases Influenza A Virus Infection by Preventing IFITM3-Mediated Restriction
  • Document date: 2013_11_21
  • ID: 10ynhrl3_21
    Snippet: We began this study with the observation that treating cells with AmphoB prevented IFITM3-mediated restriction. Upon investigating this phenomenon, we found that overcoming IFITM3 is a principal component of AmphoB-enhanced IAV infection, both confirming and significantly extending a previous study reported during this investigation (Roethl et al., 2011) . Of consequence, we also showed that by neutralizing IFITM3's block to viral fusion, AmphoB .....
    Document: We began this study with the observation that treating cells with AmphoB prevented IFITM3-mediated restriction. Upon investigating this phenomenon, we found that overcoming IFITM3 is a principal component of AmphoB-enhanced IAV infection, both confirming and significantly extending a previous study reported during this investigation (Roethl et al., 2011) . Of consequence, we also showed that by neutralizing IFITM3's block to viral fusion, AmphoB removed more than 60% of IFN's protective effects against IAV in vitro.

    Search related documents:
    Co phrase search for related documents
    • IAV infection and previous study: 1, 2, 3
    • IAV infection and protective effect: 1, 2, 3, 4
    • IAV infection and viral fusion: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • IAV protective effect and protective effect: 1, 2
    • previous study and principal component: 1
    • previous study and protective effect: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • previous study and viral fusion: 1, 2, 3, 4, 5, 6, 7
    • principal component and protective effect: 1, 2, 3
    • protective effect and viral fusion: 1, 2, 3